Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) shares rose 7.1% during trading on Friday . The stock traded as high as $162.30 and last traded at $163.3070. Approximately 149,335 shares changed hands during trading, a decline of 90% from the average daily volume of 1,450,710 shares. The stock had previously closed at $152.55.
Direxion Daily S&P Biotech Bull 3x Shares Stock Performance
The business has a 50-day simple moving average of $137.56 and a two-hundred day simple moving average of $93.59.
Hedge Funds Weigh In On Direxion Daily S&P Biotech Bull 3x Shares
Several institutional investors have recently bought and sold shares of the company. Squarepoint Ops LLC raised its position in Direxion Daily S&P Biotech Bull 3x Shares by 33.2% during the 2nd quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock worth $9,171,000 after buying an additional 40,157 shares during the last quarter. Tower Research Capital LLC TRC raised its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 664.7% during the third quarter. Tower Research Capital LLC TRC now owns 58,171 shares of the company’s stock worth $5,445,000 after purchasing an additional 50,564 shares in the last quarter. IMC Chicago LLC acquired a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at about $3,806,000. JPMorgan Chase & Co. purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter valued at approximately $3,208,000. Finally, Virtu Financial LLC purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter valued at approximately $1,757,000.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
See Also
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Where Do I Find 52-Week Highs and Lows?
- 4 High-Potential ETFs for 2026: Small Caps, Space Stocks, and More
- 3 Fintech Stocks With Good 2021 Prospects
- META Rises Amid Tech Decline, Trump’s AI Order Praised By Analyst
- Investing in Commodities: What Are They? How to Invest in Them
- TL;DR: Why Reddit is the New Growth Stock to Beat
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
